Danwei Huangfu

In this engaging discussion, Dr. Danwei Huangfu, a stem cell researcher at Memorial Sloan Kettering, delves into her groundbreaking work on gene editing and human development. She explains how her team utilizes CRISPR technology to manipulate human pluripotent stem cells to induce pancreatic beta cells, which could advance diabetes treatment. Danwei highlights the limitations of mouse models compared to human stem cells and the exciting prospects of immune engineering for cell therapy. Her insights into CRISPR screens showcase revolutionary paths for future research.